Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer

Kroon, J.; Puhr, M.; Buijs, J.T.; Horst, G. van der; Hemmer, D.M.; Marijt, K.A.; ... ; Pluijm, G. van der (2016)

Article / Letter to editor

• docetaxel
• glucocorticoid receptor
• prostate cancer
• therapy resistance

• All authors: Kroon, J.; Puhr, M.; Buijs, J.T.; Horst, G. van der; Hemmer, D.M.; Marijt, K.A.; Hwang, M.S.; Masood, M.; Grimm, S.; Storm, G.; Metselaar, J.M.; Meijer, O.C.; Culig, Z.; Pluijm, G. van der
• Date: 2016-01-31
• Journal: Endocrine-Related Cancer
• Volume: 23
• Issue: 1
• Pages: 35 - 45
• DOI: doi:10.1530/ERC-15-0343